Literature DB >> 22377654

Temporal effect of Afro-Caribbean race on serum pregnancy-associated plasma protein-a at 9-13 weeks' gestation in screening for aneuploidies.

Susan Ball1, David Wright, Danielle Sodre, Robert Lachmann, Kypros H Nicolaides.   

Abstract

OBJECTIVE: It was the aim of this study to investigate the pregnancy characteristics that influence the measured concentrations of maternal serum-free β-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A) at 9(+0)-13(+6) weeks' gestation.
METHODS: In singleton pregnancies attending for routine care, serum-free β-hCG and PAPP-A were measured at 9(+0)-13(+6) weeks' gestation and fetal nuchal translucency was measured at 11(+0)-13(+6) weeks. The population included 27,908 chromosomally normal and 104 trisomy 21 pregnancies. Multiple regression analysis was used to examine the pregnancy characteristics that have a significant effect on the measured concentrations of free β-hCG and PAPP-A. We also examined the impact of incorporating temporal effects on performance of screening for trisomy 21.
RESULTS: Serum-free β-hCG and PAPP-A concentrations were significantly affected by gestational age, maternal weight, racial origin, parity, preexisting diabetes mellitus type 2, smoking and conception by in vitro fertilization. There was a significant gestational age-dependent effect of Afro-Caribbean race on PAPP-A levels (p = 0.0005), with a weekly increase of 4.9% (95% CI 2.1-7.8).
CONCLUSIONS: Serum-free β-hCG and PAPP-A concentrations at 9(+0)-13(+6) weeks' gestation are affected by several pregnancy characteristics and the effect of Afro-Caribbean race on PAPP-A increases with gestational age.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22377654     DOI: 10.1159/000336252

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  4 in total

1.  Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study.

Authors:  Tim I M Korevaar; Eric A P Steegers; Yolanda B de Rijke; Sarah Schalekamp-Timmermans; W Edward Visser; Albert Hofman; Vincent W V Jaddoe; Henning Tiemeier; Theo J Visser; Marco Medici; Robin P Peeters
Journal:  Eur J Epidemiol       Date:  2015-05-12       Impact factor: 8.082

2.  Pregnancy Associated Plasma Protein-A and Placental Growth Factor in a Sub-Saharan African Population: A Nested Cross-Sectional Study.

Authors:  Joyce L Browne; Kerstin Klipstein-Grobusch; Maria P H Koster; Dhivya Ramamoorthy; Edward Antwi; Idder Belmouden; Arie Franx; Diederick E Grobbee; Peter C J I Schielen
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

3.  First Trimester Aneuploidy Screening Markers in Women with Pre-Gestational Diabetes Mellitus.

Authors:  Padmalatha Gurram; Peter Benn; James Grady; Anne-Marie Prabulos; Winston Campbell
Journal:  J Clin Med       Date:  2014-05-08       Impact factor: 4.241

4.  Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women.

Authors:  Edward Antwi; Kerstin Klipstein-Grobusch; Joyce L Browne; Peter C Schielen; Kwadwo A Koram; Irene A Agyepong; Diederick E Grobbee
Journal:  Reprod Health       Date:  2018-03-27       Impact factor: 3.223

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.